Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol ; volume:12 ; number:1 ; day:22 ; month:11 ; year:2022 ; pages:1-7 ; date:12.2022
Scientific reports ; 12, Heft 1 (22.11.2022), 1-7, 12.2022
- Urheber
-
Chait, Yossi
Nathanson, Brian H.
Germain, Michael J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-23262-1
- URN
-
urn:nbn:de:101:1-2023020409384190452040
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chait, Yossi
- Nathanson, Brian H.
- Germain, Michael J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ferric pyrophosphate citrate: interactions with transferrin
Physicochemical characterization of ferric pyrophosphate citrate
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis
Antiviral effects of ferric ammonium citrate
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
Nitrate Reductase from Chlorella Vulgaris. Reaction with Mangani-Pyrophosphate and with Ferric-o-Phenanthroline
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study
Ferric pyrophosphate citrate: interactions with transferrin
Physicochemical characterization of ferric pyrophosphate citrate
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis
Antiviral effects of ferric ammonium citrate
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
Nitrate Reductase from Chlorella Vulgaris. Reaction with Mangani-Pyrophosphate and with Ferric-o-Phenanthroline
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study
Ferric pyrophosphate citrate: interactions with transferrin
Physicochemical characterization of ferric pyrophosphate citrate
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis
Antiviral effects of ferric ammonium citrate
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney Disease
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
Nitrate Reductase from Chlorella Vulgaris. Reaction with Mangani-Pyrophosphate and with Ferric-o-Phenanthroline